Welcome to the PET-CT Tumor Evaluation and Radionuclide Therapy Training Program
MedicalPoint Hospital presents a comprehensive training program designed for nuclear medicine physicians, oncologists, radiologists, and healthcare professionals seeking specialized expertise in PET-CT imaging and radionuclide cancer therapies. This program combines in-depth theoretical instruction with hands-on practical experience in diagnostic and therapeutic nuclear medicine, particularly in oncology.
Why Train at MedicalPoint Hospital?
- High case volume with a wide range of tumor types and treatment scenarios
- Multidisciplinary training in collaboration with oncology, radiology, and nuclear medicine teams
- Modern PET-CT imaging and radionuclide therapy infrastructure
- Globally recognized faculty and evidence-based, case-focused education
- Certification awarded upon completion of the program
Program Duration: 1 to 2 weeks (customized by experience level)
Location: MedicalPoint Hospital – Nuclear Medicine & Oncology Education Unit
Format: Theoretical lectures + workshops + live clinical observation
Certification: PET-CT Tumor Evaluation and Radionuclide Therapy Certificate
Theoretical Training Modules
1. Introduction to PET-CT in Oncology
- Functional and anatomical imaging: PET vs. CT
- Common tracers: FDG, PSMA, DOTA-based radiopharmaceuticals
- Clinical indications for PET-CT in cancer care
- Advantages and limitations for diagnosis, staging, and prognosis
2. Tumor Imaging and Evaluation with PET-CT
- Tumor metabolism and uptake patterns
- PET-CT protocols for lung, breast, colorectal, and lymphomas
- Imaging for metastasis, recurrence, and treatment response
- Interpretation of standard uptake values (SUVs) and imaging artifacts
3. Radionuclide Therapy: Basics and Applications
- Radioisotopes and their mechanisms of action
- Indications and dosimetry for systemic and targeted radionuclide therapy
- Role in personalized oncology and non-invasive therapy
- Radiation safety and handling of radiopharmaceuticals
4. Radionuclide Therapy for Specific Tumors
- I-131 therapy for differentiated thyroid cancer
- Lu-177 DOTATATE for neuroendocrine tumors
- Lu-177 PSMA for metastatic prostate cancer
- Y-90 for liver metastases and lymphomas
5. PET-CT in Treatment Planning and Monitoring
- PET-CT in RT planning and dosimetric accuracy
- Monitoring tumor viability, regression, or progression
- Integration with MRI, CT, and biopsy for a holistic approach
- Use of PET in pre- and post-therapeutic evaluation
6. Complications and Risk Management in Radionuclide Therapy
- Managing hematologic, renal, and gastrointestinal side effects
- Long-term follow-up and patient counseling
- Regulatory considerations and radiation protection protocols
- Emergency protocols for adverse reactions
Practical / Hands-On Training Modules
1. PET-CT Imaging Workshops
- Protocol development for cancer-specific imaging
- Patient preparation, radiotracer injection, and scanning
- Image post-processing and SUV quantification
- Case review and interdisciplinary diagnosis
2. Radionuclide Therapy Techniques
- Patient eligibility and therapy planning
- Administering I-131, Lu-177, and other therapeutic agents
- Radiation shielding and isolation protocols
- Patient follow-up and therapy outcome documentation
3. Tumor Evaluation and Treatment Planning Using PET-CT
- Developing treatment algorithms using PET-based assessments
- Reviewing multidisciplinary tumor board decisions
- Personalized therapy pathways based on molecular imaging
4. Live Case Observation and Participation
- Observing PET-CT scans and therapy administration (2–3/day)
- Real-time decision-making in clinical oncology settings
- Follow-up scans and response evaluations
5. Case Presentations and Expert Debriefs
- Presenting oncology cases from imaging through treatment
- Review of success metrics, resistance, or recurrence
- Faculty-led discussion of best practices and treatment innovations
Final Evaluation & Certification
Upon successful completion of clinical and academic modules, participants will receive a Certificate of Achievement in PET-CT Tumor Evaluation and Radionuclide Therapy from MedicalPoint Hospital.
Contact & Registration
Email: [email protected]
Website: www.medicalpointinternational.com
Location: MedicalPoint Hospital – Nuclear Medicine & Oncology Education Center
WHAT WE'RE TALKING ABOUT
Weight Loss and GLP-1 Therapy: A Modern Approach to Sustainable Weight Management
Life During and After IVF Treatment: What Patients Should Know
Prostate Cancer Treatment in Turkey
